Entellus Medical (ENTL) Misses Q4 EPS by 1c

Entellus Medical (NASDAQ: ENTL) reported Q4 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $18.1 million versus the consensus estimate of $17.52 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $73-77 million, versus the consensus of $74 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79